The 9th Dermatology Drug Development Summit is the definitive industry-led forum bringing together a driven community of experts pioneering innovative drug discovery and clinical strategies to improve long-term outcomes for patients with immuno-inflammatory disease. With disease heterogeneity and biomarker discovery fueling a new wave of research, and clinical pipelines facing intensifying competition, the need to develop differentiated, novel candidates has never been more critical.

As the field accelerates with clinical and commercial momentum, highlighted by Sanofi’s continued success with Dupixent, Corvus’ promising Phase 1 data on Soquelitinib, and landmark deals such as Gilead’s $1.7B inflammation partnership with LEO Pharma – this summit provides an essential platform to stay ahead of the curve. Returning this November, the meeting unites 120+ leading experts from pharma, biotech, and academia, all dedicated to overcoming the most pressing R&D bottlenecks in dermatology drug development.

Attendees will gain insights into the latest preclinical and clinical findings across both rare and common conditions, including atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, pemphigus nodularis, bullous pemphigoid, and alopecia areata. Sessions will explore the complexity of disease heterogeneity, emerging mechanisms of action, safety considerations, and the evolving regulatory landscape. With contributions from thought leaders at AbbVie, Sanofi, Takeda, Incyte, Merck, and other trailblazing organizations, discussions will span discovery, preclinical, translational, clinical, and medical affairs perspectives.

The program also offers a forward-looking exploration of the modalities reshaping dermatology pipelines, from bispecifics and biologics to oligonucleotides and beyond. By combining cutting-edge science with real-world clinical and strategic insights, the 9th Dermatology Drug Development Summit equips participants with the tools to accelerate innovation, navigate increasing competition, and ultimately deliver therapies that transform patient quality of life.

If you’d like to learn more about the summit, download the event guide or get in touch!